We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Husseini Manji.
- Authors
Manji, Husseini; Mullard, Asher
- Abstract
An interview with Janssen head of neuroscience Husseini Manji is presented. In this article, Manji talks about the circumstances that led to the ongoing development of esketamine to treat patients suffering from long-term depression, and the process towards conducting Phase III trials after testing intravenous and intranasal formulations of the drug. He mentions that esketamine will initially be used for patients with treatment-resistant depression.
- Subjects
MANJI, Husseini; NEUROSCIENCES; MENTAL depression; CLINICAL trials; MEDICAL research; MENTAL illness drug therapy; MENTAL illness; INDUSTRIES; ANTIDEPRESSANTS; KETAMINE
- Publication
Nature Reviews Drug Discovery, 2015, Vol 14, Issue 11, p742
- ISSN
1474-1776
- Publication type
interview
- DOI
10.1038/nrd4771